Aganitha
Mentions
1
Across all reports
Quality Score
15/ 100
New
First Seen
May 27, 2026
Indexed in atlas
Last Seen
3h ago
Most recent reference
Positioning
Synthesized from 1 mentionAganitha offers an AI platform that screens millions of molecules for properties like binding affinity. They focus on speed and accuracy using deep learning. Pricing is subscription-based, likely $50k-$100k/year. They also provide consulting services.
Strengths
3 cited- AI-first approach
- Fast screening
- Cloud-based
Weaknesses
3 cited- New entrant
- Limited validation
- Small team
Recent mentions
Showing 1 of 1- direct3h ago
Virtual Screening Platform for Drug Discovery Teams
virtualscreeningplatformdrugdiscoveryteams
Validate something like Aganitha
Use Aganitha as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.